BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25739012)

  • 1. DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell lines.
    Neradil J; Pavlasova G; Sramek M; Kyr M; Veselska R; Sterba J
    Oncol Rep; 2015 May; 33(5):2169-75. PubMed ID: 25739012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacologic rationale for high-dose methotrexate.
    Jolivet J
    NCI Monogr; 1987; (5):61-5. PubMed ID: 2448656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
    Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
    Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.
    Sweeney CL; Diers MD; Frandsen JL; Gunther R; Verfaillie CM; McIvor RS
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1075-84. PubMed ID: 11861818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
    Scionti I; Michelacci F; Pasello M; Hattinger CM; Alberghini M; Manara MC; Bacci G; Ferrari S; Scotlandi K; Picci P; Serra M
    Ann Oncol; 2008 Aug; 19(8):1500-1508. PubMed ID: 18385200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
    Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
    Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
    Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
    J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate therapy with leucovorin rescue: in vitro investigations on human osteosarcoma cell lines.
    Diddens H; Teufel T; Niethammer D
    Cancer Chemother Pharmacol; 1987; 20(2):128-32. PubMed ID: 3499251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD; Smith AK; Kamen BA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro].
    Wang J; Yin JQ; Jia Q; Shen JN; Huang G; Xie XB; Zou CY
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):734-8. PubMed ID: 21163061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG; Nowickyj SM; Walker VK
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
    May C; James RI; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1444-51. PubMed ID: 8819532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes.
    Lächelt U; Wittmann V; Müller K; Edinger D; Kos P; Höhn M; Wagner E
    Mol Pharm; 2014 Aug; 11(8):2631-9. PubMed ID: 24754871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2.
    Wang YP; Yang ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Apr; 37(2):215-20. PubMed ID: 25936711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.